The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3

Endocrinology

Volumn 141, Issue 2, 2000, Pages 564-570

  Coverley, J A ^a   Martin, J L ^a   Baxter, R C ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CELL DNA; CYSTEINE PROTEINASE; PHOSPHORUS; PHOSPHOSERINE; PLASMIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DEGLYCOSYLATION; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME SUBUNIT; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REACTION ANALYSIS; VIRUS CELL TRANSFORMATION;

EID: 0034464043     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.2.7306     Document Type: Article

References (41)

1. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily
2. r 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity labeling
3. Circulating binding proteins for the insulinlike growth factors
4. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts
5. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism
6. Induction of the growth inhibitor IGF-binding protein 3 by p53
7. Insulin-like growth factor binding protein-3 inhibits gonadotropin-induced ovulation, oocyte maturation, and steroidogenesis in rabbit ovary
8. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
9. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type I IGF receptor gene
10. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
11. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
12. Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from human fibroblasts by different mechanisms
13. Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells
14. Nuclear transport of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in opossum kidney cells
15. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
16. Insulin-like growth factor-binding protein from human plasma. Purification and characterization
17. Structural determinants of ligand and cell-surface binding of insulin-like growth factor-binding protein-3
18. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
19. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain
20. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
21. Phosphorylation of insulin-like growth factor binding proteins
22. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells
23. Identification of the major sites of phosphorylation in IGF binding protein-3
24. Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I
25. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
26. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3
27. Insulin-like growth factor (IGF) binding protein-3 protease activity secreted by MCF-7 breast cancer cells: Inhibition by IGFs does not require IGF-IGFBP interaction
28. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol
29. Insulin-like growth factor binding protein IGFBP-3 is secreted as a phospho-protein
30. Regulation and function of insulin-like growth factor-binding protein-1
31. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101
32. Insulin-like growth factor binding proteins: Biochemical characterization
33. Glycosaminoglycans inhibit formation of the 140 kilodalton insulin-like growth factor-binding protein complex
34. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: Role of heparan sulfate proteoglycans
35. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
36. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
37. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule
38. Regulation of IGF bioavailability by IGFBP proteases
39. Insulin-like growth factor binding protein-3 is functionally normal in pregnancy serum
40. A proteolyhc fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
41. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding and structure of fragments